tiprankstipranks
Towa Pharmaceutical Co Ltd (JP:4553)
TSE/TYO:4553
Holding JP:4553?
Track your performance easily

Towa Pharmaceutical Co (4553) Stock Price & Analysis

0 Followers

4553 Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

7.21%90.31%
Insiders
― Other Institutional Investors
90.31% Public Companies and
Individual Investors

4553 FAQ

What was Towa Pharmaceutical Co Ltd’s price range in the past 12 months?
Towa Pharmaceutical Co Ltd lowest stock price was ¥2326.00 and its highest was ¥3330.00 in the past 12 months.
    What is Towa Pharmaceutical Co Ltd’s market cap?
    Currently, no data Available
    When is Towa Pharmaceutical Co Ltd’s upcoming earnings report date?
    Towa Pharmaceutical Co Ltd’s upcoming earnings report date is Feb 18, 2025 which is in 51 days.
      How were Towa Pharmaceutical Co Ltd’s earnings last quarter?
      Towa Pharmaceutical Co Ltd released its earnings results on Nov 12, 2024. The company reported ¥21.53 earnings per share for the quarter, missing the consensus estimate of ¥49.616 by -¥28.086.
        Is Towa Pharmaceutical Co Ltd overvalued?
        According to Wall Street analysts Towa Pharmaceutical Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Towa Pharmaceutical Co Ltd pay dividends?
          Towa Pharmaceutical Co Ltd pays a Annually dividend of ¥30 which represents an annual dividend yield of 1.92%. See more information on Towa Pharmaceutical Co Ltd dividends here
            What is Towa Pharmaceutical Co Ltd’s EPS estimate?
            Towa Pharmaceutical Co Ltd’s EPS estimate is ¥57.66.
              How many shares outstanding does Towa Pharmaceutical Co Ltd have?
              Towa Pharmaceutical Co Ltd has 51,516,000 shares outstanding.
                What happened to Towa Pharmaceutical Co Ltd’s price movement after its last earnings report?
                Towa Pharmaceutical Co Ltd reported an EPS of ¥21.53 in its last earnings report, missing expectations of ¥49.616. Following the earnings report the stock price went up 0.486%.
                  Which hedge fund is a major shareholder of Towa Pharmaceutical Co Ltd?
                  Currently, no hedge funds are holding shares in JP:4553
                  ---

                  Company Description

                  Towa Pharmaceutical Co Ltd

                  TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
                  ---

                  4553 Stock 12 Month Forecast

                  Average Price Target

                  ¥3,197.73
                  ▼(-3.97% Downside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2305":"¥2,305","2752":"¥2,752","3199":"¥3,199","2528.5":"¥2,528.5","2975.5":"¥2,975.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3198.014748877984,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥3.20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3197.73457243,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥3.20K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3198.014748877984,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥3.20K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2305,2528.5,2752,2975.5,3199],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2819,2848.1549806829216,2877.3099613658437,2906.4649420487654,2935.6199227316874,2964.774903414609,2993.929884097531,3023.084864780453,3052.239845463375,3081.3948261462965,3110.5498068292186,3139.7047875121402,3168.8597681950623,{"y":3198.014748877984,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2819,2848.1334286484616,2877.2668572969233,2906.4002859453844,2935.533714593846,2964.6671432423077,2993.8005718907693,3022.9340005392305,3052.067429187692,3081.200857836154,3110.3342864846154,3139.4677151330766,3168.601143781538,{"y":3197.73457243,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2819,2848.1549806829216,2877.3099613658437,2906.4649420487654,2935.6199227316874,2964.774903414609,2993.929884097531,3023.084864780453,3052.239845463375,3081.3948261462965,3110.5498068292186,3139.7047875121402,3168.8597681950623,{"y":3198.014748877984,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2306.095,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2568.865,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2697.308,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2802.832,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2773.12,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2862.256,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2926.632,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2852.352,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2876.121,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3070,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3085,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2820,"date":1732233600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2819,"date":1733443200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Towa Pharmaceutical Co
                  Teva Pharmaceutical
                  Dr Reddy's Laboratories
                  Perrigo Company
                  Novartis
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis